Skip to main content
Clinical Trials/NCT01428830
NCT01428830CompletedNot Applicable

Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery

EngenderHealth8 sites in 8 countries524 target enrollmentStarted: January 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
524
Locations
8
Primary Endpoint
Fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test.

Study Overview

Brief Summary

This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown three months following urinary fistula repair surgery. The study will be conducted among 507 women with simple fistula presenting at 8 study sites in Sub-Saharan Africa for fistula repair surgery.

Detailed Description

A vaginal fistula is a devastating condition, affecting an estimated 2 million girls and women across Africa and Asia. Finding ways of providing services in a more efficient and cost-effective manner, without compromising surgical outcomes and the overall health of the patient, is paramount. Shortening the duration of urethral catheterization following fistula repair surgery would increase treatment capacity (by freeing available bed space and increasing availability of nursing staff), lower costs of services, and potentially lower risk of healthcare-associated infections among fistula patients. There is a lack of empirical evidence supporting any particular length of time for urethral catheterization following fistula repair surgery.

This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown. The primary outcome is fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test, a routine practice in fistula repair services. t. Secondary outcomes will include repair breakdown one week following catheter removal, intermittent catheterization due to urinary retention and the occurrence of septic or febrile episodes, prolonged hospitalization (defined as a stay at the facility beyond one week following initial catheter removal related to an adverse event), catheter blockage, and self-reported residual incontinence. This study will be conducted among 507 women with simple fistula presenting at 8 study sites for fistula repair surgery over the course of 16-18 months at each site.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Have a "simple" fistula, as determined at the end of fistula repair surgery (irrespective of the number of prior repair attempts and the cause of the fistula, with the exceptions noted under the

Exclusion Criteria

  • •Have a closed fistula at completion of surgery
  • •Have a closed fistula 7 days after surgery (i.e. at the time of randomization)
  • •Understand study procedures and requirements
  • •Agree to return to the facility for one follow-up visit three month after the date of surgery
  • •Provide informed consent to participate in the study or in the case of non-emancipated minors, both consent to the study and receive proxy consent to participate in the study
  • •Have no contraindications precluding their participation.
  • •Exclusion Criteria:
  • •Have a fistula that is determined to be "not simple" (i.e. intermediate or complex)
  • •Have a fistula that is radiation-induced, associated with cancer or due to lymphogranuloma venereum (These cases will be excluded because the healing process is very different from fistula resulting from other causes. We expect there to be few cases of these fistulas at the study sites)
  • •Have a fistula that is not closed immediately after surgery or 7 days after surgery (i.e. at the time of randomization)

Arms & Interventions

14-day catheterization

Active Comparator

Intervention: 14 day catheterization (Procedure)

7-day catheterization

Experimental

Intervention: 7-day catheterization following fistula repair surgery (Procedure)

Outcomes

Primary Outcomes

Fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test.

Time Frame: 3 months

Secondary Outcomes

  • Repair breakdown one week following catheter removal(14 days or 21 days post-repair)
  • Intermittent catheterization due to urinary retention(7 or 14 days post repair)
  • Prolonged hospitalization(14 or 21 days post-repair)
  • Catheter blockage(14 or 21 days post repair)
  • The occurrence of septic or febrile episodes(14 or 21 days post-repair)
  • Self-reported residual incontinence(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials